D. Schuster

Russell D Folks, Stamatios Lerakis, David M Schuster, 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid.

D. Schuster, J. Nye, V. Camp, 2011, Nuclear medicine and biology.

Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques

J. Hoxie, B. Vidakovic, C. Zurla, 2015, Nature Methods.

Xanthogranulomatous pyelonephritis characterized on PET/CT.

Christopher A Swingle, D. Schuster, D. Baumgarten, 2005, Clinical nuclear medicine.

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

F. Bowman, D. Schuster, A. Osunkoya, 2014, The Journal of urology.

Biodistribution and Radiation Dosimetry of the Synthetic Nonmetabolized Amino Acid Analogue Anti-18F-FACBC in Humans

J. Votaw, D. Schuster, J. Nye, 2007, Journal of Nuclear Medicine.

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer

Frode Willoch, C. Nanni, S. Fanti, 2017, The Journal of urology.

Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial

E. Schreibmann, D. Schuster, V. Master, 2017, The Journal of Nuclear Medicine.

EMPIRE-1: Randomized Trial Comparing Conventional- vs Conventional Plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer

E. Schreibmann, D. Schuster, V. Master, 2021 .

Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy

D. Schuster, V. Master, A. Jani, 2023, Clinical nuclear medicine.

The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

D. Mankoff, G. Andriole, D. Schuster, 2019, The Journal of urology.

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer

D. Schuster, V. Master, P. Nieh, 2017, Clinical nuclear medicine.

Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.

E. Schreibmann, D. Schuster, P. Rossi, 2016, International journal of radiation oncology, biology, physics.

Salvage therapy for locally recurrent prostate cancer after radiation.

D. Schuster, P. Rossi, D. Marcus, 2012, The Canadian journal of urology.

[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis

Ephraim E. Parent, D. Schuster, J. Nye, 2020, EJNMMI Research.

Update on 18F-Fluciclovine PET for Prostate Cancer Imaging

Ephraim E. Parent, D. Schuster, 2018, The Journal of Nuclear Medicine.

Initial Experience with the Radiotracer Anti-1-amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid (Anti-[18F]FACBC) with PET in Renal Carcinoma

J. Votaw, D. Schuster, P. Nieh, 2009, Molecular Imaging and Biology.

Imaging of Prostate Cancer Using Fluciclovine.

D. Schuster, L. Zanoni, B. Savir-Baruch, 2018, The Urologic clinics of North America.

ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.

Ephraim E. Parent, D. Schuster, J. McConathy, 2018, Clinical nuclear medicine.

Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer.

D. Schuster, I. Sethi, D. Brandon, 2020, Nuclear medicine communications.

Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation

F. Gleeson, D. Schuster, K. Bradley, 2018, The British journal of radiology.

Breast angiosarcoma: FDG PET findings.

Shiyong Li, D. Schuster, T. Styblo, 2009, Clinical nuclear medicine.

Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study

D. Schuster, M. Newell, J. Nye, 2016, The Journal of Nuclear Medicine.

Pilot Study of the Utility of the Synthetic PET Amino-Acid Radiotracer Anti-1-Amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid for the Noninvasive Imaging of Pulmonary Lesions

D. Schuster, A. Osunkoya, J. Nye, 2013, Molecular Imaging and Biology.

Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.

D. Schuster, R. Halkar, J. Galt, 2006, Clinical nuclear medicine.

Molecular imaging in breast cancer.

D. Schuster, R. Halkar, 2004, Radiologic clinics of North America.

FACBC Positron Emission Tomography-Computerized Tomography and 111 In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma : Results of a Prospective Clinical Trial

F. Bowman, D. Schuster, A. Osunkoya, 2014 .

A combined learning algorithm for prostate segmentation on 3D CT images

Rongrong Guo, Baowei Fei, David M. Schuster, 2017, Medical physics.

Focal Hepatic Hot Spot From Superior Vena Cava Occlusion Visualized on Ventilation/Perfusion Scintigraphy With Contrast-Enhanced CT Correlate.

D. Schuster, Michael Lawrence, 2016, Clinical nuclear medicine.

The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax.

S. Mukundan, D. Schuster, W. Small, 1998, Clinical nuclear medicine.

Gastrointestinal tract malignancies and positron emission tomography: an overview.

D. Schuster, R. Halkar, F. Esteves, 2006, Seminars in nuclear medicine.

MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural network.

J. Roper, D. Schuster, Tian Liu, 2022, Medical Physics (Lancaster).

Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI

Yang Lei, Tian Liu, Xiaofeng Yang, 2019, Physics in medicine and biology.

18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?

P. Hudgins, K. Magliocca, D. Schuster, 2015, European journal of radiology.

F‐18 FDG PET‐CT fusion in radiotherapy treatment planning for head and neck cancer

David Schuster, Raghuveer Halkar, Rebecca Howell, 2005, Head & neck.

A semiautomatic segmentation method for prostate in CT images using local texture classification and statistical shape modeling

Rongrong Guo, Baowei Fei, Martin Halicek, 2018, Medical physics.

Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?

P. Hudgins, K. Magliocca, D. Schuster, 2016, European journal of radiology.

Accuracy evaluation of a 3D ultrasound-guided biopsy system

Baowei Fei, John R. Votaw, David M. Schuster, 2013, Medical Imaging.

Magnetic resonance cholangiography

M. Pedrosa, D. Schuster, A. Robbins, 1995, Abdominal Imaging.

Current Clinical Practice Patterns of Self-Identified Nuclear Medicine Specialists.

A. Rosenkrantz, D. Schuster, R. Duszak, 2018, AJR. American journal of roentgenology.

Optimal Management of the Hyperkinetic Gallbladder: A Comparison of Outcomes Between Operative and Nonoperative Approaches

D. Schuster, E. Lin, I. Sethi, 2020, The American surgeon.

Metastatic Breast Lesion to the Falx Detected with PET-CT

D. Schuster, Chester Harrison, 2012, Nuclear Medicine and Molecular Imaging.

Imaging of Prostate Cancer Using Fluciclovine.

D. Schuster, L. Zanoni, B. Savir-Baruch, 2017, PET clinics.

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT

D. Schuster, M. Bilen, B. Carthon, 2022, Cancers.

PET Response Criteria for Solid Tumors Predict Survival at Three Months After Intra-Arterial Resin-Based 90Yttrium Radioembolization Therapy for Unresectable Intrahepatic Cholangiocarcinoma

D. Schuster, Hyun S Kim, M. Xing, 2014, Clinical nuclear medicine.

Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels.

D. Schuster, A. Jani, C. Marcus, 2021, American journal of nuclear medicine and molecular imaging.

Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial

D. Schuster, V. Master, A. Jani, 2022, The Journal of Nuclear Medicine.

Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance

D. Schuster, V. Master, M. Goodman, 2021, The Journal of Nuclear Medicine.

Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond.

D. Schuster, M. Hofman, J. Calais, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Reproducibility and Reliability of Anti-3-[18F]FACBC Uptake Measurements in Background Structures and Malignant Lesions on Follow-Up PET-CT in Prostate Carcinoma: an Exploratory Analysis

D. Schuster, V. Master, P. Nieh, 2015, Molecular Imaging and Biology.

Differences in Neural Activation for Object-Directed Grasping in Chimpanzees and Humans

Guy A Orban, David A Gutman, David M Schuster, 2013, The Journal of Neuroscience.

Automatic 3D segmentation of ultrasound images using atlas registration and statistical texture prior

Aaron Fenster, Baowei Fei, Xiaofeng Yang, 2011, Medical Imaging.

Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.

D. Schuster, R. Dhanasekaran, Hyun S Kim, 2012, Journal of vascular and interventional radiology : JVIR.

Do 18F-FDG PET/CT Parameters in Oropharyngeal and Oral Cavity Squamous Cell Carcinomas Indicate HPV Status?

P. Hudgins, A. Kendi, K. Magliocca, 2015, Clinical nuclear medicine.

18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review

J. Efstathiou, S. Rais-Bahrami, D. Schuster, 2021, Prostate Cancer and Prostatic Diseases.

Clinical utility of 18 F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels

D. Schuster, A. Jani, C. Marcus, 2021 .

Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.

D. Schuster, L. Martiniova, E. Efstathiou, 2020, Clinical nuclear medicine.

Multisite experience of fluciclovine (18F) PET/CT imaging in biochemically recurrent prostate cancer: Impact of clinical factors and intersite variation.

Frode Willoch, C. Nanni, S. Fanti, 2017 .

Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study

D. Schuster, I. Sethi, N. Nezami, 2021, Cancers.

Deep-learning-based extraprostatic nodal lesion segmentation on 18F-fluciclovine PET

J. Roper, J. Bradley, E. Schreibmann, 2022, Medical Imaging.

Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net

Olayinka A. Abiodun Ojo, J. Roper, D. Schuster, 2021, Physics in medicine and biology.

Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.

D. Schuster, M. Goodman, O. Kucuk, 2020, International journal of radiation oncology, biology, physics.

Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.

H. Kitajima, B. Fei, D. Schuster, 2018, European journal of radiology.

Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization

D. Schuster, M. Cristescu, D. Brandon, 2022, CardioVascular and Interventional Radiology.

Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.

D. Schuster, I. Sethi, D. Brandon, 2021, Journal of vascular and interventional radiology : JVIR.

Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma

D. Schuster, M. Elsayed, B. Majdalany, 2021, CardioVascular and Interventional Radiology.

Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study

S. Kappadath, D. Schuster, I. Sethi, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: a prospective single-arm clinical trial.

D. Schuster, I. Sethi, M. Cristescu, 2022, Journal of vascular and interventional radiology : JVIR.

Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

J. Bernhard, B. Shuch, A. Pantuck, 2023, Journal of Clinical Oncology.

Amino Acid Metabolism as a Target for Breast Cancer Imaging.

D. Schuster, G. Ulaner, 2018, PET clinics.

ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.

Adam T Froemming, O. Akin, A. Oto, 2023, Journal of the American College of Radiology : JACR.

A molecular image-directed, 3D ultrasound-guided biopsy system for the prostate

Aaron Fenster, Baowei Fei, Hamed Akbari, 2012, Medical Imaging.

A PET/CT Directed, 3D Ultrasound-Guided Biopsy System for Prostate Cancer

Aaron Fenster, Baowei Fei, Hamed Akbari, 2011, Prostate Cancer Imaging.

Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake

B. Fei, C. Moreno, D. Schuster, 2013 .

Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.

B. Fei, C. Moreno, D. Schuster, 2013, American journal of nuclear medicine and molecular imaging.

90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival

D. Schuster, M. Xing, H. S. Kim, 2016, Clinical nuclear medicine.

Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines

D. Schuster, M. Goodman, M. Ono, 2013, Brain Research.

ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females.

B. Patel, O. Akin, A. Oto, 2020, Journal of the American College of Radiology : JACR.

ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females.

Adam T Froemming, Jaron J. R. Chong, Oto, 2020, Journal of the American College of Radiology : JACR.

¹¹¹In OctreoScan SPECT-MRI fusion for the detection of a pancreatic insulinoma.

Diego R. Martín, D. Schuster, T. Fox, 2012, Clinical nuclear medicine.

Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.

D. Schuster, R. Subramaniam, N. Saba, 2017, American journal of nuclear medicine and molecular imaging.

Jejunal diverticular hemorrhage localized by red blood cell scintigraphy.

W. E. Chapman, D. Schuster, P. Ahearne, 2001, Clinical nuclear medicine.

Case Study of Anti-1-Amino-3-F-18 Fluorocyclobutane-1-Carboxylic Acid (Anti-[F-18] FACBC) to Guide Prostate Cancer Radiotherapy Target Design

D. Schuster, A. Jani, T. Fox, 2009, Clinical nuclear medicine.

Evaluation of Treatment Response in Patients with Breast Cancer.

D. Schuster, G. Ulaner, S. Muzahir, 2023, PET clinics.

PET-directed, 3D Ultrasound-guided prostate biopsy.

Baowei Fei, Viraj A Master, David M Schuster, 2013, Diagnostic imaging Europe.

Increased expression of Ki-67 correlates with synthetic amino acid PET radiotracer uptake in prostate cancer

B. Fei, D. Schuster, V. Master, 2012 .

Automatic segmentation of the prostate on CT images using deep learning and multi-atlas fusion

Rongrong Guo, Ling Ma, Baowei Fei, 2017, Medical Imaging.

Combining population and patient-specific characteristics for prostate segmentation on 3D CT images

Rongrong Guo, Xiabi Liu, Ling Ma, 2016, SPIE Medical Imaging.

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).

B. Helfand, M. Preston, D. Somford, 2023, European urology.

Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.

D. Schuster, Tian Liu, M. Torres, 2013, International journal of radiation oncology, biology, physics.

Role of novel imaging in the management of prostate cancer.

Ronald C. Chen, D. Schuster, A. Jani, 2019, Urologic oncology.

The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care.

D. Schuster, R. Duszak, K. Applegate, 2015, Academic radiology.

ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer.

Adam T Froemming, O. Akin, A. Oto, 2018, Journal of the American College of Radiology.

Pretreatment Staging of Muscle-Invasive Bladder Cancer

Adam T Froemming, Mdh, O. Akin, 2017 .

Indeterminate adrenal masses.

D. Schuster, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A semiautomatic approach for prostate segmentation in MR images using local texture classification and statistical shape modeling

Zhenfeng Zhang, Lizhi Liu, Baowei Fei, 2019, Medical Imaging.

Original Article Characterization of primary prostate carcinoma by anti-1-amino-2-( 18 F) -fluorocyclobutane-1-carboxylic acid (anti-3-( 18 F) FACBC) uptake

B. Fei, C. Moreno, D. Schuster, 2013 .

Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.

D. Schuster, M. Goodman, Y. Shirakami, 2012, Nuclear medicine and biology.

Differences in Neural Activation for Object-Directed Grasping in Chimpanzees and Humans

G. Orban, L. Parr, D. Gutman, 2013, The Journal of Neuroscience.

Imaging of Prostate Cancer Using Fluciclovine.

D. Schuster, L. Zanoni, B. Savir-Baruch, 2017, PET clinics.

Hyperspectral imaging and quantitative analysis for prostate cancer detection.

Luma V. Halig, H. Akbari, B. Fei, 2012, Journal of biomedical optics.

Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting

D. Schuster, K. Applegate, Yanli Zhou, 2013, Annals of Nuclear Medicine.

F-18-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

E. Schreibmann, D. Schuster, P. Rossi, 2022 .

ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.

Ephraim E. Parent, D. Schuster, J. McConathy, 2018, Clinical nuclear medicine.

Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?

P. Hudgins, K. Magliocca, D. Schuster, 2016, AJR. American journal of roentgenology.

Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT

D. Schuster, A. Osunkoya, V. Master, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Deep learning-based three-dimensional segmentation of the prostate on computed tomography images

Baowei Fei, Martin Halicek, Maysam Shahedi, 2019, Journal of medical imaging.

Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

D. Schuster, B. Siegel, B. Gartrell, 2023, The Journal of urology.

A Clinician's Guide to Nuclear Medicine

D. Schuster, N. Alazraki, A. Taylor, 2006 .